(Q41531338)

2 October 2017

1 reference

title

Combination therapy with BRMs in cancer and infectious diseases (English)

1 reference

2 October 2017

Garaci E

1

1 reference

2 October 2017

Pica F

2

1 reference

2 October 2017

Rasi G

3

1 reference

2 October 2017

Palamara AT

4

1 reference

2 October 2017

Favalli C

5

1 reference

2 October 2017

publication date

1 June 1997

1 reference

Mechanisms of Ageing and Development

2 October 2017

published in

1 reference

2 October 2017

volume

96

1 reference

2 October 2017

issue

1-3

1 reference

2 October 2017

page(s)

103-116

1 reference

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Two categories of lymphocyte unresponsiveness to phytohemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Efficacy of combination therapy with amantadine, thymosin alpha 1 and alpha/beta interferon in mice infected with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Modulation of natural killer activity by thymosin alpha 1 and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Thymosin Treatment Modulates Production of Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Pulmonary and Systemic Defenses against Challenge with Staphylococcus aureus in Mice with Pneumonia Due to Influenza A Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Production of human B and T cell growth factors is enhanced by thymic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Thymosin alpha 1 exerts protective effect against the 5-FU induced bone marrow toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

HIV/AIDS pathogenesis and treatment: new twists and turns

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Polarized assembly of enveloped viruses from cultured epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Influenza: Response of T-Cell Lymphopenia to Thymosin

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

How human immunodeficiency virus ravages the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Local cellular defenses in influenza-infected lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by Nα-desacetylthymosin αl

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Cytotoxic T Cells in the Lungs of Mice Infected with an Influenza A Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

The immunology of HIV infection: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2897%2901895-2

7 January 2021

10.1016/S0047-6374(97)01895-2

Identifiers

DOI

1 reference

2 October 2017

1 reference